What Is Levocetirizine Used For?

Levocetirizine is an antihistamine prescribed primarily for two conditions: allergic rhinitis (hay fever and year-round nasal allergies) and chronic urticaria (persistent hives). It belongs to the second generation of antihistamines, meaning it was designed to block histamine’s effects without causing the heavy drowsiness that older drugs are known for. Though it is closely related to cetirizine, the relationship between the two drugs is more interesting than a simple rebrand, and understanding it helps explain why levocetirizine exists in the first place.

The Relationship to Cetirizine

Cetirizine is a mixture of two mirror-image molecules. One of those mirror images, the R-enantiomer, is where virtually all of the antihistamine activity comes from. That R-enantiomer is levocetirizine. The other half, S-cetirizine, contributes little useful effect. So taking 5 mg of levocetirizine delivers roughly the same drug exposure as taking 10 mg of cetirizine, because you’re getting only the active half without the inactive baggage.¹ Research into the binding behavior of these two mirror molecules shows that levocetirizine latches onto the histamine H1 receptor more tightly and lets go more slowly than its counterpart, which helps explain its potency at a lower dose.²

Treating Seasonal and Year-Round Allergies

The most common reason people take levocetirizine is allergic rhinitis, whether triggered by seasonal pollen or by year-round triggers like dust mites and pet dander. In a placebo-controlled trial of U.S. adults with seasonal allergies, levocetirizine produced significantly greater improvement in a composite score of five nasal and eye symptoms compared with placebo, along with meaningful gains in quality of life, work productivity, and daytime sleepiness.³ The drug covers the full range of allergic rhinitis symptoms: sneezing, runny nose, itchy eyes, and nasal congestion, though like most oral antihistamines it handles congestion less robustly than the other symptoms.

A head-to-head study in a controlled allergen exposure chamber found that levocetirizine kicked in within about an hour, compared with roughly three hours for desloratadine. By the 24-hour mark, levocetirizine was still providing greater symptom relief, and it outperformed desloratadine specifically for nasal stuffiness.⁴ That roughly one-hour onset is consistent with the drug’s behavior in other studies, where peak blood levels appear within about an hour after swallowing a tablet.

Chronic Hives

The other major approved use is chronic idiopathic urticaria, now more commonly called chronic spontaneous urticaria. This is the frustrating condition where itchy, red welts appear and recur over weeks or months with no identifiable external trigger. A double-blind trial showed that levocetirizine at its standard dose reduced the number of daily hive episodes, the number of individual welts, and overall symptom severity compared with placebo, while also improving quality of life.⁵

Some people with chronic hives don’t get enough relief from the standard 5 mg dose. International guidelines allow doctors to increase the dose of second-generation antihistamines up to four times the standard amount for stubborn hives. A study that stepped patients up through doses of 5, 10, and 20 mg found that most people who didn’t respond at the standard dose did respond at higher doses. About three-quarters of participants fell into this “responds to higher doses” category, while roughly 15% were good responders at standard doses and about 10% didn’t respond even at the highest dose. Increasing the dose improved quality of life without increasing daytime sleepiness.⁶ This dose-escalation approach has become a standard step in chronic urticaria management before considering add-on therapies like omalizumab.

How It Stacks Up Against Other Second-Generation Antihistamines

Levocetirizine, desloratadine, and fexofenadine are probably the three most commonly prescribed second-generation antihistamines worldwide. All three work, but they have different strengths. A challenge-chamber study comparing levocetirizine with fexofenadine found that both drugs started working at a similar speed, but levocetirizine maintained significantly greater symptom relief at and beyond 22 hours after a single dose, suggesting a longer duration of action.⁷

A skin-wheal suppression study comparing all three drugs found that levocetirizine and fexofenadine both significantly suppressed histamine-induced skin reactions within two to three hours, outperforming desloratadine at those early time points. By six hours, only levocetirizine still showed statistically significant suppression.⁸ None of this means fexofenadine or desloratadine are bad drugs. They simply have somewhat different profiles. Fexofenadine, for instance, is often considered the least sedating of all antihistamines and may be preferred for people who are especially sensitive to drowsiness. The choice often depends on individual response and tolerability.

Beyond Histamine Blocking

Levocetirizine does more than just sit on histamine receptors. Lab studies have shown that it inhibits the migration of eosinophils, a type of white blood cell heavily involved in allergic inflammation. Specifically, it blocks eosinophils from crossing the walls of tiny blood vessels in the skin and lungs in response to an inflammatory signal called eotaxin.⁹ This anti-inflammatory action goes beyond what you’d expect from simply blocking the itch-sneeze pathway and may contribute to levocetirizine’s effectiveness in chronic allergic conditions where ongoing tissue inflammation is part of the problem.

Drowsiness and Brain Effects

The big selling point of second-generation antihistamines is that they are supposed to not make you sleepy. The reality with levocetirizine is nuanced. A systematic review and meta-analysis of randomized trials found that levocetirizine does produce modestly more sedation than placebo. However, when compared directly to other second-generation antihistamines like fexofenadine, desloratadine, loratadine, and bilastine, there was no statistical difference in sedation rates.¹⁰ It was clearly less sedating than first-generation antihistamines, with substantially less impact on reaction time.

A brain-imaging study using PET scans measured how much levocetirizine actually occupies histamine receptors in the brain, since that’s the mechanism behind antihistamine drowsiness. After a standard dose, average brain receptor occupancy was about 8%, with no significant difference from fexofenadine. Neither drug significantly increased subjective sleepiness compared with placebo.¹¹ For context, first-generation antihistamines can occupy over 50% of brain histamine receptors, which is why they cause significant sedation. A single-digit occupancy rate means levocetirizine barely reaches the brain at standard doses.

An interesting finding from urticaria research suggests that levocetirizine may actually reduce daytime drowsiness in people with chronic hives. A randomized trial comparing levocetirizine alone to levocetirizine combined with the sedating antihistamine hydroxyzine at bedtime found that levocetirizine alone significantly reduced daytime sleepiness from baseline, while adding hydroxyzine did not improve hive control and erased the sleepiness benefit.¹² The explanation is likely straightforward: by controlling the hives and itching that disrupt sleep, levocetirizine lets people sleep better, so they feel more awake during the day. A study comparing the mood and sleep effects of several antihistamines found that people taking levocetirizine, desloratadine, and rupatadine reported less depression, anxiety, and fatigue than those taking cetirizine or hydroxyzine.¹³

Use in Children

Levocetirizine is approved for children down to six months of age, which is younger than many competing antihistamines. A six-week trial in children with seasonal allergies found that levocetirizine nearly doubled the symptom improvement seen with placebo. Nasal congestion improved, quality-of-life scores improved, and no child in the levocetirizine group dropped out due to side effects. Side effect rates were similar between the drug and placebo groups.¹⁴

In younger children, including infants aged 6 to 11 months and toddlers aged 1 to 5 years, safety trials found that the overall rate of side effects was similar between levocetirizine and placebo. No clinically significant changes in heart rhythm, laboratory values, or vital signs were observed.¹⁵ Pharmacokinetic work in school-aged children showed that the drug reaches peak levels in about an hour and suppresses histamine-induced skin reactions for roughly a full day, from one hour after dosing out to 28 hours.¹⁶

One safety signal worth noting: a review of levocetirizine in clinical practice flagged a concern about febrile seizures in infants.¹⁷ This doesn’t mean the drug causes seizures, but it’s a reminder that prescribing for very young children deserves careful attention from the pediatrician.

Common Side Effects

At its standard 5 mg dose in adults, levocetirizine is generally well tolerated. In longer-term studies of adults taking it daily for six months for year-round allergies, the most frequently reported side effects were headache (about 24%), sore throat (about 19%), flu-like illness (about 15%), fatigue (about 8%), and sleepiness (about 8%).¹⁸ Those headache and sore-throat numbers look high in isolation, but they were reported across six months of tracking, and many of these events occur at similar rates in placebo groups as well. Dry mouth is another common complaint with antihistamines in this class, though it tends to be mild.

One practical concern: levocetirizine is eliminated primarily through the kidneys. People with significantly reduced kidney function need a lower dose, and those with severe kidney impairment may need to avoid it altogether. This is different from desloratadine and fexofenadine, which rely more on liver metabolism. Your doctor or pharmacist should flag this if it applies to you.

Safety During Pregnancy and Breastfeeding

Allergies don’t pause for pregnancy, and many people understandably worry about taking antihistamines while pregnant or nursing. A human lactation study measured how much cetirizine and levocetirizine actually transfer into breast milk. The relative infant dose for levocetirizine was about 1.9% of the maternal dose, which is well below the 10% threshold that pharmacologists generally consider the cutoff for concern. No severe adverse events were reported in the infants.¹⁹ Both cetirizine and levocetirizine are among the antihistamines most commonly considered compatible with breastfeeding, though you should always confirm with your healthcare provider.

Pairing with Montelukast

Allergic rhinitis and asthma frequently coexist, and when they do, treatment that targets both can be appealing. Montelukast works through a completely different pathway than antihistamines, blocking leukotrienes rather than histamine. Combining the two drugs has been studied extensively.

A meta-analysis pooling data from controlled trials found that the montelukast-levocetirizine combination significantly improved nasal symptom scores compared with either drug alone.²⁰ A large randomized trial confirmed that the combination produced greater reductions in daytime nasal symptoms than montelukast alone, with a similar safety profile.²¹ A separate systematic review looking at both daytime and nighttime symptoms found that the combination improved both, with a slightly larger effect during the day.²²

Fixed-dose combination tablets of montelukast and levocetirizine are available in several countries, making it convenient for people who would otherwise take two separate pills. The combination is particularly relevant for people with both allergic rhinitis and asthma, since montelukast also helps with asthma control.

Cost and Access

Levocetirizine is available as a generic in many countries, which has made it quite affordable. Economic analyses have found that it is cost-effective compared to other options in its class. One evaluation looking at quality-of-life improvement per dollar spent found that levocetirizine dominated montelukast on cost-effectiveness and was also favored over desloratadine and branded fexofenadine.²³ A separate analysis focusing specifically on nasal symptom relief reached the same conclusion: levocetirizine’s cost per clinically meaningful improvement was lower than that of its comparators.²⁴

In the United States, levocetirizine was originally prescription-only (brand name Xyzal), but it became available over the counter. In many other markets, it has been available without a prescription for years. The standard adult dose is 5 mg once daily, usually taken in the evening, though there is no strict pharmacological reason it must be taken at night. Some people prefer evening dosing because any mild drowsiness that occurs will overlap with sleep.

When Levocetirizine Might Not Be the Right Choice

No single antihistamine is perfect for everyone. About 10% of people with chronic hives don’t respond to levocetirizine even at higher doses, as noted in the dose-escalation study above. People with significant kidney problems need dose adjustments or an alternative. And while the drug’s sedation profile is generally mild, some individuals are more sensitive than others. If you find that levocetirizine makes you noticeably drowsy, fexofenadine is a reasonable swap since it has the lowest brain-receptor occupancy of the commonly available second-generation antihistamines.²⁵

For people who are already taking cetirizine and tolerating it well, switching to levocetirizine doesn’t necessarily provide a dramatic improvement. The main practical advantage is taking a smaller pill with the same effect. Where levocetirizine stands out most clearly is for people starting fresh on an antihistamine for stubborn allergies or chronic hives and wanting something with fast onset, long duration, and a strong evidence base across age groups.